FDA Approved: ISONIAZID — Supplemental Application (CMP Pharma, Inc.)

View source ↗

Summary

FDA approved CMP Pharma, Inc.'s supplemental application for isoniazid, updating the approved product under an abbreviated new drug application (ANDA).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Latent Tuberculosis Infection
• Tuberculosis

Drugs mentioned

• ISONIAZID (ISONIAZID)

Snippet

SUPPL AP for ISONIAZID (ISONIAZID)